NQO1 and colonic neoplasm: Notably, NQO1 bioactivatable quinone drugs, specifically β-lapachone (β-LPC) and KP372-18 (Jiao et al., 2022), outperform the conventional 5-fluorouracil (5-FU) in terms of killing efficiency in STEAP4-overexpressing colon tumor cells.